Metabolic Studies on the Possible Mode of Action of Isoniazid Tumorigenicity

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 1981 Jan 1

PMID 6166614

Citations 1

Authors

S V Bhide

G B Maru

N B Mate

M Menon

P Gangadharan

Affiliations

Soon will be listed here.

Abstract

Data on tumorigenicity and mutagenicity of INH show that INH is tumorigenic in mice but not in rats. The metabolic studies on the two species denote that rats are rapid inactivators whereas mice are slow inactivators of INH. Rats are also resistant to the immediate inhibitory effect of INH on DNA biosynthesis. Using Ames test it was observed that INH is mutagenic to salmonella typhimurium strains TA 100 and 1535 and this effect is abolished in presence off 59 mixture. In vivo and in vitro studies on INH interaction with macromolecules reveal that there is a greater interaction with RNA than with DNA and the site of interaction is the cytidine and deoxycytidine, respectively. A preliminary study is undertaken to see if healed TB cases have a higher risk for cancer. It is found that cancer incidence in this group is higher as compared to noncancer patients.

Citing Articles

Carcinogenicity study in mice on pildralazine, a hydralazinelike antihypertensive compound.

Della Porta G, Dragani T J Cancer Res Clin Oncol. 1983; 106(2):97-101.

PMID: 6630287 DOI: 10.1007/BF00395386.

References

Kandarkar S, Maru G, Bhide S, SIRSAT S . An ultrastructural study of the effect of isoniazid & its antitoxicants on mouse liver. Indian J Exp Biol. 1980; 18(2):157-62. View

Jung H . [Problems of induction of bronchial- and skin carcinoma by INH (Isoniazid) based on the example of lupous tuberculosis]. Z Erkr Atmungsorgane Folia Bronchol. 1971; 135(1):31-8. View

Kikugawa K, Hayatsu H, Ukita T . On the reaction of nucleic acids with isoniazid. Chem Biol Interact. 1970; 1(3):247-56. DOI: 10.1016/0009-2797(70)90012-8. View

FEREBEE S . Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970; 26:28-106. View

SEVERI L, Biancifiori C . Hepatic carcinogenesis in CBA-Cb-Se mice and Cb-Se rats by isonicotinic acid hydrazide and hydrazine sulfate. J Natl Cancer Inst. 1968; 41(2):331-49. View

Ellard G, Gammon P, Wallace S . The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine. Biochem J. 1972; 126(3):449-58. PMC: 1178399. DOI: 10.1042/bj1260449. View

Ames B, McCann J, Yamasaki E . Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res. 1975; 31(6):347-64. DOI: 10.1016/0165-1161(75)90046-1. View

Wimpenny J . Effect of isoniazid on biosynthesis in Mycobacterium tuberculosis var. bovis BCG. J Gen Microbiol. 1967; 47(3):379-88. DOI: 10.1099/00221287-47-3-379. View

Freese E, Sklarow S, Freese E . DNA damage caused by antidepressant hydrazines and related drugs. Mutat Res. 1968; 5(3):343-8. DOI: 10.1016/0027-5107(68)90004-3. View

10.

Maru G, Bhide S . Studies on inhibition of nucleic acid biosynthesis by isoniazid and its possible prevention. Arzneimittelforschung. 1980; 30(7):1115-9. View

11.

Katz S, COMB D . A NEW METHOD FOR THE DETERMINATION OF THE BASE COMPOSITION OF RIBONUCLEIC ACID. J Biol Chem. 1963; 238:3065-7. View

12.

ROHRBORN G, Propping P, Buselmaier W . Mutagenic activity of isoniazid and hydrazine in mammalian test systems. Mutat Res. 1972; 16(2):189-94. DOI: 10.1016/0027-5107(72)90179-0. View

13.

Toth B, Toth T . Investigation on the tumor producing effect of isonicotinic acid hydrazide in ASW-Sn mice and MRC rats. Tumori. 1970; 56(6):315-24. DOI: 10.1177/030089167005600601. View

14.

Lenghel V . Isoniazid-induced chromosome aberrations. Lancet. 1971; 2(7715):93. DOI: 10.1016/s0140-6736(71)92065-4. View

15.

Tosk J, Schmeltz I, Hoffmann D . Hydrazines as mutagens in a histidine-requiring auxotroph of Salmonella typhimurium. Mutat Res. 1979; 66(3):247-52. DOI: 10.1016/0165-1218(79)90085-5. View

16.

Miller C, Neutel C, Nair R, Marrett L, Last J, Collins W . Relative importance of risk factors in bladder carcinogenesis. J Chronic Dis. 1978; 31(1):51-6. DOI: 10.1016/0021-9681(78)90080-2. View

17.

HAMMOND E, SELIKOFF I, ROBITZEK E . Isoniazid therapy in relation to later occurrence of cancer in adults and in infants. Br Med J. 1967; 2(5555):792-5. PMC: 1843149. DOI: 10.1136/bmj.2.5555.792. View

18.

Bartmann K, MASSMANN W . [Experimental studies on dosage of isoniazid]. Beitr Klin Tuberk Spezif Tuberkuloseforsch. 1961; 124:310-9. View

19.

Toth B, SHUBIK P . Carcinogenesis in Swiss mice by isonicotinic acid hydrazide. Cancer Res. 1966; 26(7):1473-5. View

20.

Maru G, Sawai M, Bhide S . Prevention of isoniazid tumorigenicity by antitoxicants of isoniazid in Swiss mice. J Cancer Res Clin Oncol. 1980; 97(2):145-51. DOI: 10.1007/BF00409900. View